Lee Ainslie Horizon Therapeutics Public LTD CO Transaction History

Maverick Capital LTD

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$71.83 - $95.48 $134,393 - $178,643	-1,871 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$67.0 - $84.39 $125,357 - $157,893	1,871 New	1,871 $137,000
Q2 2020 Aug 14, 2020	SELL	$30.2 - $56.98 $1.6 Million - $3.03 Million	-53,141 Closed	0 $0
Q1 2020 May 15, 2020	SELL	$24.87 - $38.56 $1.85 Million - $2.86 Million	-74,295 Reduced 58.3%	53,141 $1.57 Million
Q4 2019 Feb 14, 2020	SELL	$25.43 - $36.67 $1.02 Million - $1.47 Million	-40,187 Reduced 23.97%	127,436 $4.61 Million
Q3 2019 Nov 14, 2019	SELL	$23.0 - $27.97 $1.05 Million - $1.28 Million	-45,657 Reduced 21.41%	167,623 $4.56 Million
Q2 2019 Aug 14, 2019	BUY	$22.81 - $28.48 $4.86 Million - $6.07 Million	213,280 New	213,280 $5.13 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Maverick Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Maverick Capital LTD and Lee Ainslie with notifications on news.